Valuation: Shandong Linuo Pharmaceutical Packaging Co., Ltd.

Market Cap 6.89B 1.03B 915M 848M 771M 1.46B 97.67B 1.48B 10.19B 4B 50.97B 3.86B 3.78B 162B P/E 2026 *
68.1x
P/E 2027 * 52x
Enterprise Value 6.89B 1.03B 915M 848M 771M 1.46B 97.67B 1.48B 10.19B 4B 50.97B 3.86B 3.78B 162B EV / Sales 2026 *
6.32x
EV / Sales 2027 * 5.56x
Free-Float
62.75%
Yield 2026 *
-
Yield 2027 * -
09-21 Shandong Linuo Pharmaceutical Packaging Co., Ltd.(XSEC:301188) added to S&P Global BMI Index CI
08-24 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
06-03 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2025, Payable on 9 June 2026 CI
04-22 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-22 Shandong Linuo Pharmaceutical Packaging Co., Ltd. announces Annual dividend, payable on June 09, 2026 CI
04-21 Shandong Linuo Pharmaceutical Packaging Co., Ltd. announced that it expects to receive CNY 300 million in funding CI
04-07 Nuode Fund Management Co., Ltd., Caitong Fund Management Co., Ltd., Jinxiu Zhonghe Investment Management Co., Ltd. and Allianz Asset Management Co., Ltd acquired 2.99% stake in Shandong Linuo Pharmaceutical Packaging Co., Ltd. from Linuo Investment Holding Group Co., Ltd. for approximately CNY 130 million. CI
03-31 Shandong Linuo Pharmaceutical Packaging's controlling shareholder plans to sell 3.0% stake RE
12-15 Tranche Update on Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback Plan announced on February 7, 2025. CI
12-15 Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback announced on February 7, 2025, has closed with 4,557,700 shares, representing 1.99% for CNY 81.11 million. CI
11-04 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Approves Board Elections CI
27/10/25 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
09/10/25 Tranche Update on Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback Plan announced on February 7, 2025. CI
1 day+0.34%
1 week-10.34%
Current month-20.25%
1 month-20.30%
3 months-30.19%
6 months+5.91%
Current year+50.80%
1 week 26.1
Extreme 26.1
29.66
1 month 26.1
Extreme 26.1
38.86
Current year 15.07
Extreme 15.07
76.3
1 year 15.07
Extreme 15.07
76.3
3 years 10.78
Extreme 10.78
76.3
5 years 10.78
Extreme 10.78
76.3
10 years 10.78
Extreme 10.78
76.3
Manager TitleAgeSince
Chief Executive Officer 46 15/04/2024
Director of Finance/CFO 45 29/11/2022
Investor Relations Contact - -
Director TitleAgeSince
Chairman 51 31/10/2025
Chairman 47 01/01/2024
Director/Board Member 54 06/04/2015
Change 5-day change 1-year change 3-year change Capi.($)
+0.34%-10.34%+57.51%+114.90% 1.03B
+0.25%+5.11%+7.61%-0.90% 20.26B
+1.61%+4.19%-17.98%+39.90% 18.63B
+0.64%+8.11%+30.77%+38.69% 16.73B
-0.32%+4.46%+9.95%-4.86% 13.29B
+0.41%+5.44%+21.64%+38.01% 12.27B
+0.49%+2.92%+25.75%+74.29% 11.73B
+1.42%+3.46%+15.83%-15.26% 8.96B
+0.20%+3.43%-3.73%-2.33% 7.92B
0.00%-12.61%+67.50%+649.62% 5.88B
Average +0.50%+2.94%+21.49%+93.21% 11.67B
Weighted average by Cap. +0.57%+4.52%+13.73%+55.11%

Financials

2026 *2027 *
Net sales 1.09B 163M 145M 134M 122M 230M 15.46B 234M 1.61B 633M 8.07B 611M 598M 25.72B 1.24B 185M 164M 152M 139M 262M 17.56B 266M 1.83B 718M 9.16B 694M 680M 29.21B
Net income 103M 15.39M 13.68M 12.68M 11.54M 21.77M 1.46B 22.12M 152M 59.77M 762M 57.77M 56.54M 2.43B 137M 20.47M 18.2M 16.87M 15.35M 28.96M 1.94B 29.43M 203M 79.5M 1.01B 76.84M 75.21M 3.23B
Net Debt - -
Projected Income Statement - Annual - Shandong Linuo Pharmaceutical Packaging Co., Ltd.
Logo Shandong Linuo Pharmaceutical Packaging Co., Ltd.
Shandong Linuo Pharmaceutical Packaging Co Ltd, formerly Shandong Linuo Technical Glass Co Ltd, is a China-based company specialized in the research, development, production and sales of borosilicate special glass. The Company's main products include medium borosilicate pharmaceutical glass and high borosilicate heat-resistant glass series products. Pharmaceutical glass products include low borosilicate pharmaceutical glass series and medium borosilicate pharmaceutical glass series, which are mainly used in medical packaging fields such as blood products, biopharmaceuticals, new drugs and special drugs, vaccines, etc. High borosilicate heat-resistant glass products include heat-resistant glassware, glass trays for microwave ovens, glass lenses, electric light source glass shells and electric light source glass tubes, and others, which are mainly used in residential life fields including dining utensils, kitchen utensils, lighting fixtures, and others.
Employees
1,403
Date Price Change Volume
16/10/26 CN¥26.54 +0.34% 8,553,403
15/10/26 CN¥26.45 -4.92% 7,335,293
14/10/26 CN¥27.82 -3.34% 6,689,685
13/10/26 CN¥28.78 +0.07% 9,198,890
12/10/26 CN¥28.76 -2.84% 8,394,652

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Shandong Linuo Pharmaceutical Packaging Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 301188 Stock